These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15632187

  • 21. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
    Wang HL.
    J Neurochem; 1997 Apr; 68(4):1728-35. PubMed ID: 9084447
    [Abstract] [Full Text] [Related]

  • 22. Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.
    Gigoux V, Escrieut C, Silvente-Poirot S, Maigret B, Gouilleux L, Fehrentz JA, Gully D, Moroder L, Vaysse N, Fourmy D.
    J Biol Chem; 1998 Jun 05; 273(23):14380-6. PubMed ID: 9603948
    [Abstract] [Full Text] [Related]

  • 23. Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C.
    Ho MK, Yung LY, Chan JS, Chan JH, Wong CS, Wong YH.
    Br J Pharmacol; 2001 Apr 05; 132(7):1431-40. PubMed ID: 11264236
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S, Nunn C, Zupanc GK, Hoyer D.
    Auton Autacoid Pharmacol; 2005 Jan 05; 25(1):1-16. PubMed ID: 15659149
    [Abstract] [Full Text] [Related]

  • 27. High-affinity CCK receptors are coupled to phospholipase A2 pathways to mediate pancreatic amylase secretion.
    Tsunoda Y, Owyang C.
    Am J Physiol; 1995 Sep 05; 269(3 Pt 1):G435-44. PubMed ID: 7573455
    [Abstract] [Full Text] [Related]

  • 28. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M, Ren Y, Gordon MC, Hsu JE, Beinborn M, Kopin AS.
    Mol Pharmacol; 1998 Nov 05; 54(5):857-63. PubMed ID: 9804620
    [Abstract] [Full Text] [Related]

  • 29. Coupling of canine serotonin 5-HT(1B) and 5-HT(1D) receptor subtypes to the formation of inositol phosphates by dual interactions with endogenous G(i/o) and recombinant G(alpha15) proteins.
    Wurch T, Pauwels PJ.
    J Neurochem; 2000 Sep 05; 75(3):1180-9. PubMed ID: 10936201
    [Abstract] [Full Text] [Related]

  • 30. Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding.
    Dong M, Vattelana AM, Lam PC, Orry AJ, Abagyan R, Christopoulos A, Sexton PM, Haines DR, Miller LJ.
    Mol Pharmacol; 2015 Jan 05; 87(1):130-40. PubMed ID: 25319540
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors.
    Rose PM, Krystek SR, Patel PS, Liu EC, Lynch JS, Lach DA, Fisher SM, Webb ML.
    FEBS Lett; 1995 Mar 20; 361(2-3):243-9. PubMed ID: 7698331
    [Abstract] [Full Text] [Related]

  • 33. Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
    Desai AJ, Lam PC, Orry A, Abagyan R, Christopoulos A, Sexton PM, Miller LJ.
    J Med Chem; 2015 Dec 24; 58(24):9562-77. PubMed ID: 26654202
    [Abstract] [Full Text] [Related]

  • 34. Common structural basis for constitutive activity of the ghrelin receptor family.
    Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW.
    J Biol Chem; 2004 Dec 17; 279(51):53806-17. PubMed ID: 15383539
    [Abstract] [Full Text] [Related]

  • 35. Construction of a high affinity zinc binding site in the metabotropic glutamate receptor mGluR1: noncompetitive antagonism originating from the amino-terminal domain of a family C G-protein-coupled receptor.
    Jensen AA, Sheppard PO, Jensen LB, O'Hara PJ, Bräuner-Osborne H.
    J Biol Chem; 2001 Mar 30; 276(13):10110-8. PubMed ID: 11133983
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.
    Galés C, Poirot M, Taillefer J, Maigret B, Martinez J, Moroder L, Escrieut C, Pradayrol L, Fourmy D, Silvente-Poirot S.
    Mol Pharmacol; 2003 May 30; 63(5):973-82. PubMed ID: 12695525
    [Abstract] [Full Text] [Related]

  • 39. Phosphatidylinositol 4,5-bisphosphate modifies tubulin participation in phospholipase Cbeta1 signaling.
    Popova JS, Greene AK, Wang J, Rasenick MM.
    J Neurosci; 2002 Mar 01; 22(5):1668-78. PubMed ID: 11880496
    [Abstract] [Full Text] [Related]

  • 40. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R, Escrieut C, Gigoux V, De K, Clerc P, Niu F, Azema J, Masri B, Cordomi A, Baltas M, Tikhonova IG, Fourmy D.
    J Am Chem Soc; 2013 Feb 20; 135(7):2560-73. PubMed ID: 23323542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.